Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
TME Alteration in HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
- Status
- RECRUITING
- Phase
- PHASE2
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
HER-2 B Cell Peptide Vaccine
- Status
- RECRUITING
- Phase
- PHASE1
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
- Status
- COMPLETED
- Phase
- N/A
Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
- Status
- RECRUITING
- Phase
- PHASE2
The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
- Status
- RECRUITING
- Phase
- NA
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
- Status
- RECRUITING
- Phase
- NA
A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
- Status
- RECRUITING
- Phase
- NA